Stabilization of atherosclerotic plaques: An update

Seppo Ylä-Herttuala; Jacob Fog Bentzon; Mat Daemen; Erling Falk; Hector M. Garcia-Garcia; Joerg Herrmann; Imo Hoefer; Suvi Jauhiainen; J. Wouter Jukema; Rob Krams; Brenda R. Kwak; Nikolaus Marx; Marek Naruszewicz; Andrew Newby; Gerard Pasterkamp; Patrick W.J.C. Serruys; Johannes Waltenberger; Christian Weber; Lale Tokgözoglu

doi:10.1093/eurheartj/eht301

Stabilization of atherosclerotic plaques: An update

Seppo Ylä-Herttuala, Jacob Fog Bentzon, Mat Daemen, Erling Falk, Hector M. Garcia-Garcia, Joerg Herrmann, Imo Hoefer, Suvi Jauhiainen, J. Wouter Jukema, Rob Krams, Brenda R. Kwak, Nikolaus Marx, Marek Naruszewicz, Andrew Newby, Gerard Pasterkamp, Patrick W.J.C. Serruys, Johannes Waltenberger, Christian Weber, Lale Tokgözoglu

Cardiovascular Medicine

Research output: Contribution to journal › Comment/debate › peer-review

67 Scopus citations

Original language	English (US)
Pages (from-to)	3251-3258
Number of pages	8
Journal	European heart journal
Volume	34
Issue number	42
DOIs	https://doi.org/10.1093/eurheartj/eht301
State	Published - Nov 7 2013

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1093/eurheartj/eht301

Cite this

Ylä-Herttuala, S., Bentzon, J. F., Daemen, M., Falk, E., Garcia-Garcia, H. M., Herrmann, J., Hoefer, I., Jauhiainen, S., Jukema, J. W., Krams, R., Kwak, B. R., Marx, N., Naruszewicz, M., Newby, A., Pasterkamp, G., Serruys, P. W. J. C., Waltenberger, J., Weber, C., & Tokgözoglu, L. (2013). Stabilization of atherosclerotic plaques: An update. European heart journal, 34(42), 3251-3258. https://doi.org/10.1093/eurheartj/eht301

Stabilization of atherosclerotic plaques : An update. / Ylä-Herttuala, Seppo; Bentzon, Jacob Fog; Daemen, Mat; Falk, Erling; Garcia-Garcia, Hector M.; Herrmann, Joerg; Hoefer, Imo; Jauhiainen, Suvi; Jukema, J. Wouter; Krams, Rob; Kwak, Brenda R.; Marx, Nikolaus; Naruszewicz, Marek; Newby, Andrew; Pasterkamp, Gerard; Serruys, Patrick W.J.C.; Waltenberger, Johannes; Weber, Christian; Tokgözoglu, Lale.

In: European heart journal, Vol. 34, No. 42, 07.11.2013, p. 3251-3258.

Research output: Contribution to journal › Comment/debate › peer-review

Ylä-Herttuala, S, Bentzon, JF, Daemen, M, Falk, E, Garcia-Garcia, HM, Herrmann, J, Hoefer, I, Jauhiainen, S, Jukema, JW, Krams, R, Kwak, BR, Marx, N, Naruszewicz, M, Newby, A, Pasterkamp, G, Serruys, PWJC, Waltenberger, J, Weber, C & Tokgözoglu, L 2013, 'Stabilization of atherosclerotic plaques: An update', European heart journal, vol. 34, no. 42, pp. 3251-3258. https://doi.org/10.1093/eurheartj/eht301

Ylä-Herttuala, Seppo ; Bentzon, Jacob Fog ; Daemen, Mat ; Falk, Erling ; Garcia-Garcia, Hector M. ; Herrmann, Joerg ; Hoefer, Imo ; Jauhiainen, Suvi ; Jukema, J. Wouter ; Krams, Rob ; Kwak, Brenda R. ; Marx, Nikolaus ; Naruszewicz, Marek ; Newby, Andrew ; Pasterkamp, Gerard ; Serruys, Patrick W.J.C. ; Waltenberger, Johannes ; Weber, Christian ; Tokgözoglu, Lale. / Stabilization of atherosclerotic plaques : An update. In: European heart journal. 2013 ; Vol. 34, No. 42. pp. 3251-3258.

@article{f5cad0c2fc4f41fe9d0872c117055f6e,

title = "Stabilization of atherosclerotic plaques: An update",

author = "Seppo Yl{\"a}-Herttuala and Bentzon, {Jacob Fog} and Mat Daemen and Erling Falk and Garcia-Garcia, {Hector M.} and Joerg Herrmann and Imo Hoefer and Suvi Jauhiainen and Jukema, {J. Wouter} and Rob Krams and Kwak, {Brenda R.} and Nikolaus Marx and Marek Naruszewicz and Andrew Newby and Gerard Pasterkamp and Serruys, {Patrick W.J.C.} and Johannes Waltenberger and Christian Weber and Lale Tokg{\"o}zoglu",

note = "Funding Information: Conflict of interest: I.H. has received research grants from NWO, CTMM, BMM, and TI Pharma. J.W.J. has received grants from Astellas, Astra-Zeneca, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Medtronic, MSD, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi-Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands, and the European Community Framework FP7 Programme. R.K. has received grants from the Netherlands and British Heart Foundations, the CTMM, the BBSRC and EPSRC, the FP7 Programme, and Johnson & Johnson. B.R.K. has received grants from the Swiss National Science Foundation, Fondation Leenaards, and the Fondation Prevot. N.M. has received research grants from Boehringer Ingelheim, GSK, MSD, and Takeda. A.N. has received grants from the British Heart Foundation and the UK National Institute for Health Research. He is also consultant for PlaqueTec. G.P. is a co-founder of Cavadis. C.W. is a shareholder of Carolus Therapeutics, Inc. S.Y.-H has received grants from the Academy of Finland, the Finnish Heart Foundation, and EU FP7 programme grants CliniGene, Baculogenes, BIOMAGSCAR, and BAMI. Funding Information: This study was supported by ESC Working Group of Atherosclerosis and Vascular Biology.",

year = "2013",

month = nov,

day = "7",

doi = "10.1093/eurheartj/eht301",

language = "English (US)",

volume = "34",

pages = "3251--3258",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "42",

}

TY - JOUR

T1 - Stabilization of atherosclerotic plaques

T2 - An update

AU - Ylä-Herttuala, Seppo

AU - Bentzon, Jacob Fog

AU - Daemen, Mat

AU - Falk, Erling

AU - Garcia-Garcia, Hector M.

AU - Herrmann, Joerg

AU - Hoefer, Imo

AU - Jauhiainen, Suvi

AU - Jukema, J. Wouter

AU - Krams, Rob

AU - Kwak, Brenda R.

AU - Marx, Nikolaus

AU - Naruszewicz, Marek

AU - Newby, Andrew

AU - Pasterkamp, Gerard

AU - Serruys, Patrick W.J.C.

AU - Waltenberger, Johannes

AU - Weber, Christian

AU - Tokgözoglu, Lale

N1 - Funding Information: Conflict of interest: I.H. has received research grants from NWO, CTMM, BMM, and TI Pharma. J.W.J. has received grants from Astellas, Astra-Zeneca, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Medtronic, MSD, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi-Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands, and the European Community Framework FP7 Programme. R.K. has received grants from the Netherlands and British Heart Foundations, the CTMM, the BBSRC and EPSRC, the FP7 Programme, and Johnson & Johnson. B.R.K. has received grants from the Swiss National Science Foundation, Fondation Leenaards, and the Fondation Prevot. N.M. has received research grants from Boehringer Ingelheim, GSK, MSD, and Takeda. A.N. has received grants from the British Heart Foundation and the UK National Institute for Health Research. He is also consultant for PlaqueTec. G.P. is a co-founder of Cavadis. C.W. is a shareholder of Carolus Therapeutics, Inc. S.Y.-H has received grants from the Academy of Finland, the Finnish Heart Foundation, and EU FP7 programme grants CliniGene, Baculogenes, BIOMAGSCAR, and BAMI. Funding Information: This study was supported by ESC Working Group of Atherosclerosis and Vascular Biology.

PY - 2013/11/7

Y1 - 2013/11/7

UR - http://www.scopus.com/inward/record.url?scp=84890473570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890473570&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/eht301

DO - 10.1093/eurheartj/eht301

M3 - Comment/debate

C2 - 23966311

AN - SCOPUS:84890473570

VL - 34

SP - 3251

EP - 3258

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 42

ER -